Press Releases | PTC Therapeutics, Inc.

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Year

Oct 04, 2016

New Research Validates Translarna's™ (ataluren) Mechanism of Action to Promote Readthrough of Nonsense Mutations and Produce Full-length Functional Protein

- Data published in the Proceedings of National Academy of Sciences (PNAS) -
- Results show ataluren targets the protein production machinery -

Sep 12, 2016

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J. , Sept. 12, 2016 /PRNewswire/ -- PTC Therapeutics , Inc. ( NASDAQ : PTCT) today announced that on September 8, 2016 it approved non-statutory stock options to purchase an aggregate of 22,900 shares of its common stock to eleven new employees.

Sep 07, 2016

PTC Therapeutics Recognizes World Duchenne Awareness Day by Announcing Winners of Global Duchenne Muscular Dystrophy Patient Group Awards and Expanding Disease State Awareness Website

- STRIVE Awards Program Recognizes Excellence and Innovation in the Duchenne Muscular Dystrophy Community -
- PTC's Disease Awareness Website - www.DuchenneAndYou.com now available in multiple languages -

Aug 04, 2016

PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update

-- Translarna™ net sales of $15.4M representing 150% year-over-year growth --
-- Full-year Translarna net sales on-track to meet guidance of $65M to $85M --
-- NHS England and NICE agreement completed allowing reimbursed access --
-- EMA review of European marketing authorization for Translarna continues --
-- FDA appeal process initiated in the U.S. --

Jul 25, 2016

PTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren)

SOUTH PLAINFIELD, N.J. , July 25, 2016 /PRNewswire/ -- PTC Therapeutics, Inc. ( NASDAQ : PTCT) today announced global regulatory updates on Translarna ™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD) and nonsense mutation cystic fibrosis (nmCF).

Jul 21, 2016

PTC Therapeutics to Host Conference Call to Discuss Second Quarter Financial Results

SOUTH PLAINFIELD, N.J. , July 21, 2016 /PRNewswire/ -- PTC Therapeutics, Inc. ( NASDAQ : PTCT) today announced that the Company will host a webcast conference call to report its second quarter financial results and provide an update on the company's business and outlook on Thursday, August 4, 2016

Jul 07, 2016

NHS England Enables Access to Translarna™ ▼ (ataluren) For Patients with Nonsense Mutation Duchenne Muscular Dystrophy

--Important decision allows reimbursed access to Translarna, the first approved therapy to treat the underlying cause of Duchenne muscular dystrophy--

Jun 13, 2016

PTC Therapeutics Appoints Dawn Svoronos to Board of Directors

SOUTH PLAINFIELD, N.J. , June 13, 2016 /PRNewswire/ -- PTC Therapeutics, Inc. ( NASDAQ : PTCT) today announced the appointment of Dawn Svoronos to the company's Board of Directors. Ms. Svoronos most recently served as President of Merck's Europe / Canada region from 2009 to 2011 and as President

Jun 10, 2016

New Analyses from Phase 3 Study 009 of Translarna™ (ataluren) in Patients with Cystic Fibrosis Presented at 39th European Cystic Fibrosis Conference

SOUTH PLAINFIELD, N.J. , June 10, 2016 /PRNewswire/ -- PTC Therapeutics, Inc. ( NASDAQ : PTCT) today announced that new analyses from the company's previous Phase 3, double-blind, placebo-controlled, 48-week 009 trial of Translarna™ (ataluren) for the treatment of nonsense mutation cystic fibrosis

May 16, 2016

PTC Therapeutics Announces Winners of the Global Cystic Fibrosis Patient Group Awards

STRIVE Awards Program Recognizes Excellence and Innovation in the Cystic Fibrosis Community

Pagination

First page
Previous page
…
Page 38
Page 39
Current page 40
Page 41
Page 42
…
Next page
Last page